Immunosuppressants work by lowering the activity of the immune system, and while there is no strong evidence that GLP-1 drugs interfere with these treatments, potential interactions should always be evaluated on a case-by-case basis

Skin reactions may result from: Immune-mediated hypersensitivity to the active semaglutide molecule itself Reactions to pharmaceutical excipients , particularly phenol or other preservatives Local tissue irritation from the subcutaneous injection process Formation of anti-drug antibodies , though this occurs in fewer than 1% of patients according to the EMA European Public Assessment Report (EPAR) for Ozempic Factors that may potentially increase susceptibility to Ozempic skin reactions include: Previous allergic reactions to other GLP-1 receptor agonists (such as liraglutide or dulaglutide) History of atopic conditions although evidence specifically linking atopy to increased risk of semaglutide reactions is limited Multiple drug allergies or known hypersensitivity to injectable medications Improper injection technique , such as injecting too superficially or failing to rotate injection sites Concurrent skin conditions at the injection site To minimise injection site reactions, avoid injecting into areas of infection, lipodystrophy, scars or active dermatitis

Semaglutide overdose symptoms include severe nausea, vomiting, and potentially dangerous drops in blood sugar
Curcumin may affect levels of many medications as discussed in our Turmeric and Curcumin Supplements Review, which includes our Top Picks for turmeric and curcumin
Plan your refills around both your dose consumption rate and the beyond-use date
What factors influence the success of semaglutide for weight loss